ORIGINAL RESEARCH
Published on 09 Sep 2024
Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States
doi 10.3389/fimmu.2024.1464092
- 1,896 views
- 4 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Streamlining Drug Approvals: Addressing Policy Challenges in Genitourinary Oncology
Streamlining Drug Approvals: Addressing Policy Challenges in Genitourinary Oncology
695
Total downloads
2,681
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: